Given the diversity and breadth of immunodominant CD4 and CD8 antigens demonstrated herein, and by Lindestam Arlehamn et al.,29 novel TB vaccines may require inclusion of several antigenic targets to provide efficacy. This evidence concerns the gene CD4 and tuberculosis.